Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 1411 AL 1425

A 12-week multidomain intervention versus active control to reduce risk of Alzheimer's disease: study protocol for a randomized controlled trial

Anstey KJ, Bahar-Fuchs A, Herath P, Rebok GW, Cherbuin N.

Trials. 2013 Feb 27;14:60. doi: 10.1186/1745-6215-14-60.

Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study

Takahashi R, Ishii K, Senda M, Ito K, Ishii K, Kato T, Makishi Y, Nishio T, Ikari Y, Iwatsubo T; Japanese Alzheimer’s Disease Neuroimaging Initiative.

Ann Nucl Med. 2013 Jun;27(5):452-9. doi: 10.1007/s12149-013-0704-x. Epub 2013 Mar 13.

Cognitive impairment and diabetes

Dash SK.

Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):155-65. doi: 10.2174/1872214811307020009.

Utility of the AD8 as a self-rating tool for cognitive impairment in an Asian population

Chin R, Ng A, Narasimhalu K, Kandiah N.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):284-8. doi: 10.1177/1533317513481090. Epub 2013 Mar 14.

The mini-Kingston Standardized Cognitive Assessment

Hopkins RW, Kilik LA.

Am J Alzheimers Dis Other Demen. 2013 May;28(3):239-44. doi: 10.1177/1533317513481095. Epub 2013 Mar 28.

[Assessment of mild cognitive impairment and dementia in epidemiologic studies. An overview on the current state of research in Germany]

Then FS, Luck T, Jacobi F, Berger K, Weyerer S, Grabe HJ, Busch MA, Wagner M, Riedel-Heller SG.

Psychiatr Prax. 2013 May;40(4):183-91. doi: 10.1055/s-0033-1343138. Epub 2013 Apr 5.

Psychosis of Alzheimer disease: prevalence, incidence, persistence, risk factors, and mortality

Vilalta-Franch J, López-Pousa S, Calvó-Perxas L, Garre-Olmo J.

Am J Geriatr Psychiatry. 2013 Nov;21(11):1135-43. doi: 10.1016/j.jagp.2013.01.051. Epub 2013 Feb 6.

MR imaging features of amyloid-related imaging abnormalities

Barakos J, Sperling R, Salloway S, Jack C, Gass A, Fiebach JB, Tampieri D, Melançon D, Miaux Y, Rippon G, Black R, Lu Y, Brashear HR, Arrighi HM, Morris KA, Grundman M.

AJNR Am J Neuroradiol. 2013 Oct;34(10):1958-65. doi: 10.3174/ajnr.A3500. Epub 2013 Apr 11.

Alzheimer's disease risk, obesity and tau: is insulin resistance guilty?

Blum D, Buée L.

Expert Rev Neurother. 2013 May;13(5):461-3. doi: 10.1586/ern.13.35.

Antihypertensives, angiotensin, glucose and Alzheimer's disease

Nelson L, Tabet N, Richardson C, Gard P.

Expert Rev Neurother. 2013 May;13(5):477-82. doi: 10.1586/ern.13.32.

Optimal blood pressure for cognitive function: findings from an elderly African-American cohort study

Liu H, Gao S, Hall KS, Unverzagt FW, Lane KA, Callahan CM, Hendrie HC.

J Am Geriatr Soc. 2013 Jun;61(6):875-881. doi: 10.1111/jgs.12259. Epub 2013 May 6.

When aging-onset diabetes is coming across with Alzheimer disease: comparable pathogenesis and therapy

Tang J, Pei Y, Zhou G.

Exp Gerontol. 2013 Aug;48(8):744-50. doi: 10.1016/j.exger.2013.04.013. Epub 2013 May 4.

Posterior cortical atrophy and Alzheimer's disease: a meta-analytic review of neuropsychological and brain morphometry studies

Alves J, Soares JM, Sampaio A, Gonçalves OF.

Brain Imaging Behav. 2013 Sep;7(3):353-61. doi: 10.1007/s11682-013-9236-1.

Evaluation of a computer-assisted errorless learning-based memory training program for patients with early Alzheimer's disease in Hong Kong: a pilot study

Lee GY, Yip CC, Yu EC, Man DW.

Clin Interv Aging. 2013;8:623-33. doi: 10.2147/CIA.S45726. Epub 2013 Jun 7.

Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease

Daulatzai MA.

Neurotox Res. 2013 Oct;24(3):407-59. doi: 10.1007/s12640-013-9407-2. Epub 2013 Jul 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias